Literature DB >> 18810600

Relationship between clinical course and Diffusion-weighted MRI findings in sporadic Creutzfeldt-Jakob Disease.

Sang-Hun Yi1, Key-Chung Park, Sung-Sang Yoon, Eui-Jong Kim, Won-Chul Shin.   

Abstract

The aim of this study was to investigate the relationship between clinical course and diffusion-weighted MRI (DWI) findings in sporadic Creutzfeldt-Jakob Disease (sCJD). We reviewed clinical records and MRI examination in nine probable sCJD. According to hyperintense signal distribution on DWI, the patients were classified into two groups with cortical ribbon plus basal ganglia hyperintensity (6/9) and with only increased cortical signals (3/9). Clinical features including quadriparesis (3/6), akinetic mutism (2/6), and dysphasia (2/6), which were usually observed in the more advanced stage of CJD, were noted only in patients with cortical ribbon plus basal ganglia hyperintensity at the time of initial DWI examination. The patients with the cortical plus basal ganglia hyperintensity (6.4+/-1.7 weeks) had a shorter interval from symptom onset to akinetic mutism than those with only cortical ribbon hyperintensity (26.0+/-22.5 weeks) (p=0.02). These findings suggest that DWI may predict the clinical course of CJD.

Entities:  

Mesh:

Year:  2008        PMID: 18810600     DOI: 10.1007/s10072-008-0976-4

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


  20 in total

1.  Detection of 14-3-3 protein in the CSF of a patient with Hashimoto's encephalopathy.

Authors:  L E Hernández Echebarría; A Saiz; F Graus; J Tejada; J M García; B Clavera; F Fernández
Journal:  Neurology       Date:  2000-04-11       Impact factor: 9.910

2.  [Diffusion-weighted MRI in patients with Creutzfeldt-Jakob disease].

Authors:  S Kropp; M Finkenstaedt; I Zerr; A Schröter; S Poser
Journal:  Nervenarzt       Date:  2000-02       Impact factor: 1.214

3.  Creutzfeldt-Jakob disease: serial changes on diffusion-weighted MRI.

Authors:  M Matoba; H Tonami; H Miyaji; H Yokota; I Yamamoto
Journal:  J Comput Assist Tomogr       Date:  2001 Mar-Apr       Impact factor: 1.826

4.  The 14-3-3 brain protein in cerebrospinal fluid as a marker for transmissible spongiform encephalopathies.

Authors:  G Hsich; K Kenney; C J Gibbs; K H Lee; M G Harrington
Journal:  N Engl J Med       Date:  1996-09-26       Impact factor: 91.245

5.  Current clinical diagnosis in Creutzfeldt-Jakob disease: identification of uncommon variants.

Authors:  I Zerr; W J Schulz-Schaeffer; A Giese; M Bodemer; A Schröter; K Henkel; H J Tschampa; O Windl; A Pfahlberg; B J Steinhoff; O Gefeller; H A Kretzschmar; S Poser
Journal:  Ann Neurol       Date:  2000-09       Impact factor: 10.422

6.  Chronological changes in MRI and CSF biochemical markers in Creutzfeldt-Jakob disease patients.

Authors:  Katsuya Satoh; Susumu Shirabe; Hiroto Eguchi; Akira Tsujino; Masakatsu Motomura; Akira Satoh; Mitsuhiro Tsujihata; Katsumi Eguchi
Journal:  Dement Geriatr Cogn Disord       Date:  2007-03-26       Impact factor: 2.959

7.  Abnormal diffusion-weighted magnetic resonance images in Creutzfeldt-Jakob disease.

Authors:  M M Bahn; P Parchi
Journal:  Arch Neurol       Date:  1999-05

8.  Clinical course in young patients with sporadic Creutzfeldt-Jakob disease.

Authors:  Constanze Boesenberg; Walter J Schulz-Schaeffer; Bettina Meissner; Kai Kallenberg; Mario Bartl; Uta Heinemann; Anna Krasnianski; Katharina Stoeck; Daniela Varges; Otto Windl; Hans A Kretzschmar; Inga Zerr
Journal:  Ann Neurol       Date:  2005-10       Impact factor: 10.422

9.  Sporadic Creutzfeldt-Jakob disease: magnetic resonance imaging and clinical findings.

Authors:  B Meissner; K Körtner; M Bartl; U Jastrow; B Mollenhauer; A Schröter; M Finkenstaedt; O Windl; S Poser; H A Kretzschmar; I Zerr
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

10.  Predictors of survival in sporadic Creutzfeldt-Jakob disease and other human transmissible spongiform encephalopathies.

Authors:  M Pocchiari; M Puopolo; E A Croes; H Budka; E Gelpi; S Collins; V Lewis; T Sutcliffe; A Guilivi; N Delasnerie-Laupretre; J-P Brandel; A Alperovitch; I Zerr; S Poser; H A Kretzschmar; A Ladogana; I Rietvald; E Mitrova; P Martinez-Martin; J de Pedro-Cuesta; M Glatzel; A Aguzzi; S Cooper; J Mackenzie; C M van Duijn; R G Will
Journal:  Brain       Date:  2004-09-10       Impact factor: 13.501

View more
  5 in total

1.  Sporadic Creutzfeldt-Jacob Disease: An 8-Year Experience from a Single Center in Turkey.

Authors:  Özlem Taşkapilioğlu; Meral Seferoğlu; Şükran Yurtoğullari; Bahattin Hakyemez; Sevda Erer; Necdet Karli; Mustafa Bakar; Ö Faruk Turan; Mehmet Zarifoğlu; Şahsine Tolunay; İbrahim Bora
Journal:  Noro Psikiyatr Ars       Date:  2013-12-01       Impact factor: 1.339

2.  Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course.

Authors:  Jae Hyoung Kim; Byung Se Choi; Cheolkyu Jung; YoungHee Chang; SangYun Kim
Journal:  Neuroradiology       Date:  2011-01-11       Impact factor: 2.804

3.  Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease.

Authors:  Ting Gao; Jin-Hao Lyu; Jia-Tang Zhang; Xin Lou; Wei Zhao; Xiao-Wei Xing; Ming Yang; Yan Yao; Qing-Che Tan; Cheng-Lin Tian; Xu-Sheng Huang; Lin Ma; Sheng-Yuan Yu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

4.  Evolution of Diffusion-Weighted Magnetic Resonance Imaging Signal Abnormality in Sporadic Creutzfeldt-Jakob Disease, With Histopathological Correlation.

Authors:  Laura Eisenmenger; Marie-Claire Porter; Christopher J Carswell; Andrew Thompson; Simon Mead; Peter Rudge; John Collinge; Sebastian Brandner; Hans R Jäger; Harpreet Hyare
Journal:  JAMA Neurol       Date:  2016-01       Impact factor: 18.302

5.  Neuroanatomical correlates of prion disease progression - a 3T longitudinal voxel-based morphometry study.

Authors:  Enrico De Vita; Gerard R Ridgway; Mark J White; Marie-Claire Porter; Diana Caine; Peter Rudge; John Collinge; Tarek A Yousry; Hans Rolf Jager; Simon Mead; John S Thornton; Harpreet Hyare
Journal:  Neuroimage Clin       Date:  2016-11-02       Impact factor: 4.881

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.